Sublicensing Royalties. At such times from time to time as Company may receive Sublicensing Royalties, Company will pay some or all thereof to Licensor, as follows:
Sublicensing Royalties. (i) In consideration of the rights granted by Indevus hereunder, during the Agreement Term, Esprit shall pay Indevus sublicensing royalties equal to twelve and one-half percent (12.5%) of aggregate Net Sales in the Field in the Territory in each Calendar Year (“Sublicensing Royalties”), subject to Section 6.2(a)(ii).
Sublicensing Royalties. Except as otherwise provided in Section 5.6 below, Licensee shall pay Caltech fifteen percent (15%) of the Net Revenues (including payments for technical assistance and the like) that Licensee receives from sublicensing with respect to Exclusively Licensed Patent Rights. For non-monetary consideration, Licensee, may, in its sole discretion, and when feasible, provide Caltech with fifteen percent (15%) of such non-monetary consideration. Such Net Revenues specifically shall not include payments made by a sublicensee solely in consideration of: (a) equity or debt securities of Licensee; (b) to support research or development activities to be undertaken by Licensee; (c) upon the achievement by Licensee of specified milestones or benchmarks relating to the development of Licensed Products; (d) pilot studies; (e) performance-based milestones (excluding milestones tied to sales or marketing performance, which shall be subject to the percentage-based payments to Caltech); (f) the license or sublicense of any intellectual property other than Caltech Technology; (g) products other than Licensed Products; or (h) reimbursement for patent or other expenses.
Sublicensing Royalties. As appropriate, sublicensing royalty payments due Alliance from Licensee for Net Sales by Sublicensees will be at the same rate and schedule as set forth in Section C above. In addition, Licensee shall pay to Alliance an amount equal to [PERCENT SHARE] (XX%) of Sublicensing Revenues received by Licensee. Licensee will be responsible for overseeing, collecting, reporting, and submitting royalties and Sublicensing Revenues from Sublicensees to Alliance. Alliance will NOT send invoices for payments due on a fixed schedule. It is Licensee’s responsibility to make all payments in accordance with this Agreement and all late payments will be charged interest in accordance with Paragraph 4.4 of this Agreement.
Sublicensing Royalties. With respect to sublicenses granted by Licensee under Section 2A, Licensee shall pay the applicable Royalty to Licensor ########*.
Sublicensing Royalties. With respect to sublicenses granted by Licensee under Section 2(A), Licensee shall be obligated to pay the applicable Royalty to Licensor on sales of Royalty-Bearing Products by such sublicensee in each country calculated as if the Selling Price received by such sublicensee during the relevant calendar quarter for which payment of Royalty is due under Section 4(E) had been received by Licensee itself during the quarter in which such sales are reported to Licensee.
Sublicensing Royalties. SensiVida shall pay Infotonics fifty percent (50%) of all Sublicensing Revenues in accordance with section 4.5.
Sublicensing Royalties. Licensee shall pay University Sublicensing Royalties for all sublicense consideration received for the sublicense of the Patent Rights (excluding Bucindolol, and other than the sublicense of the Patent Rights to any Affiliates of Licensee) according to the following schedule: (a) [ * ], (b) [ * ] and (c) [ * ]. For purposes of this Agreement, an “Affiliate” shall mean every corporation, or entity, which, directly or indirectly, or through one or more intermediaries, controls, is controlled by, or is under common control with Licensee, as well as every officer, director, agent and representative of any such corporation or entity. For the purposes of the definition of Affiliate, the word “control” (including, with correlative meaning, the terms “controlled by” or “under common control with”) means the actual power, either directly or [*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities and Exchange Act of 1934, as amended. indirectly through one or more intermediaries, to direct or cause the direction of the management and policies of such entity, whether by ownership of at least fifty percent (50%) of the voting stock of such entity, or by contract or otherwise. Notwithstanding the foregoing, the exclusion of Royalties on Bucindolol shall apply to the Patent Rights but shall not apply to Improvements or other new Inventions involving Bucindolol that are created with the use of University facilities.
Sublicensing Royalties. LICENSEE agrees to pay PHS a sublicensing royalty of [**] percent ([**]%) of (i) up-front sublicense fees, payments or the equivalent and (ii) milestone payments attributable to LICENSED PATENT RIGHTS subject to:
Sublicensing Royalties. Royalties on sales by Sublicensees received by MitoKor under sublicense agreements of the license rights granted to MitoKor under this Agreement.
